Mesoridazine
RxNorm 6779
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 6779 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Mesoridazine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
IN
Ingredient (IN):
Mesoridazine
(Atom ID: 12252168)
PT
Designated preferred name (PT):
Mesoridazine
(Atom ID: 220770)
FN
Full form of descriptor (FN):
Mesoridazine (substance)
(Atom ID: 220781)
PT
Designated preferred name (PT):
Mesoridazine-containing product
(Atom ID: 10806836)
FN
Full form of descriptor (FN):
Product containing mesoridazine (medicinal product)
(Atom ID: 9259525)
Patient Education
Mesoridazine
Mesoridazine is used to treat the symptoms of schizophrenia and reduce restlessness, anxiety, and tension. It can also reduce hyperactivity and uncooperativeness.
[Learn More]
* Please review the disclaimer below.